Literature DB >> 19016431

Colon cancer stem cells.

Antonija Kreso1, Catherine Adell O'Brien.   

Abstract

This unit describes protocols for working with colon cancer stem cells. To work with these cells one must start by generating single-cell suspensions from human colon cancer tissue. These cell suspensions are sorted using flow cytometry-assisted cell sorting to fractionate the cells into tumor-initiating and nontumor-initiating subsets. Once the cells have been fractionated, they must be functionally tested to determine tumor-forming capacity, the gold standard being the in vivo xenograft assay. Methods have also been developed to grow these cells in vitro in a sphere-forming assay. This unit will describe how to isolate and functionally test colon cancer stem cells, as well as provide advice on the potential challenges of the research.

Entities:  

Mesh:

Year:  2008        PMID: 19016431     DOI: 10.1002/9780470151808.sc0301s7

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  18 in total

1.  Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer.

Authors:  Jeffrey Chou; Lilien N Voong; Christie L Mortales; Andrea M H Towlerton; Seth M Pollack; Xiaoji Chen; Cassian Yee; Paul F Robbins; Edus H Warren
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

2.  MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.

Authors:  Celina García-García; Martín A Rivas; Yasir H Ibrahim; María Teresa Calvo; Albert Gris-Oliver; Olga Rodríguez; Judit Grueso; Pilar Antón; Marta Guzmán; Claudia Aura; Paolo Nuciforo; Katti Jessen; Guillem Argilés; Rodrigo Dienstmann; Andrea Bertotti; Livio Trusolino; Judit Matito; Ana Vivancos; Irene Chicote; Héctor G Palmer; Josep Tabernero; Maurizio Scaltriti; José Baselga; Violeta Serra
Journal:  Clin Cancer Res       Date:  2015-08-13       Impact factor: 12.531

3.  Molecular biology and therapeutics in musculoskeletal oncology.

Authors:  Theresa A Guise; Regis O'Keefe; R Lor Randall; Richard M Terek
Journal:  J Bone Joint Surg Am       Date:  2009-03-01       Impact factor: 5.284

4.  TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence.

Authors:  Isabel Puig; Stephan P Tenbaum; Irene Chicote; Oriol Arqués; Jordi Martínez-Quintanilla; Estefania Cuesta-Borrás; Lorena Ramírez; Pilar Gonzalo; Atenea Soto; Susana Aguilar; Cristina Eguizabal; Ginevra Caratù; Aleix Prat; Guillem Argilés; Stefania Landolfi; Oriol Casanovas; Violeta Serra; Alberto Villanueva; Alicia G Arroyo; Luigi Terracciano; Paolo Nuciforo; Joan Seoane; Juan A Recio; Ana Vivancos; Rodrigo Dienstmann; Josep Tabernero; Héctor G Palmer
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

5.  CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.

Authors:  Manuele Giuseppe Muraro; Valentina Mele; Silvio Däster; Junyi Han; Michael Heberer; Giulio Cesare Spagnoli; Giandomenica Iezzi
Journal:  Stem Cells Transl Med       Date:  2012-08-06       Impact factor: 6.940

6.  Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33.

Authors:  Ninel Azoitei; Christopher M Hoffmann; Jana M Ellegast; Claudia R Ball; Kerstin Obermayer; Ulrike Gößele; Britta Koch; Katrin Faber; Felicitas Genze; Mark Schrader; Hans A Kestler; Hartmut Döhner; Gabriela Chiosis; Hanno Glimm; Stefan Fröhling; Claudia Scholl
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

Review 7.  Thyroid regeneration: how stem cells play a role?

Authors:  Shioko Kimura
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-14       Impact factor: 5.555

8.  Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures.

Authors:  Valeria Costabile; Francesca Duraturo; Paolo Delrio; Daniela Rega; Ugo Pace; Raffaella Liccardo; Giovanni Battista Rossi; Rita Genesio; Lucio Nitsch; Paola Izzo; Marina De Rosa
Journal:  Int J Oncol       Date:  2015-03-02       Impact factor: 5.650

9.  Nodal promotes the self-renewal of human colon cancer stem cells via an autocrine manner through Smad2/3 signaling pathway.

Authors:  Yuehua Gong; Ying Guo; Yanan Hai; Hao Yang; Yang Liu; Shi Yang; Zhenzhen Zhang; Meng Ma; Linhong Liu; Zheng Li; Zuping He
Journal:  Biomed Res Int       Date:  2014-02-17       Impact factor: 3.411

10.  Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice.

Authors:  Jeffrey Chou; Matthew P Fitzgibbon; Christie-Lynn L Mortales; Andrea M H Towlerton; Melissa P Upton; Raymond S Yeung; Martin W McIntosh; Edus H Warren
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.